肝过氧化物酶体增殖物激活受体γ辅激活因子1β驱动线粒体和合成代谢特征促进小鼠肝细胞癌进展
研究通过构建肝特异性过表达PGC-1β(LivPGC-1β)和敲除(LivPGC-1βKO)小鼠,在化学和遗传性肝癌模型中观察PGC-1β的作用。结果显示过表达小鼠肿瘤易感性更高,敲除小鼠受保护;PGC-1β增强ROS清除物表达并支持脂肪酸和甘油三酯合成相关基因表达,促进肿瘤合成代谢。
要点
- 肝过表达PGC-1β小鼠在化学和遗传性肝癌模型中肿瘤易感性更高。
- 肝敲除PGC-1β小鼠在相同模型中受到保护,肿瘤生长受限。
- PGC-1β增强ROS清除物表达并支持脂肪酸和甘油三酯合成基因表达。
核心结论
- 肝PGC-1β是肝细胞癌中线粒体功能和氧化还原状态的转录守门人,协调不同代谢程序以允许肿瘤进展。
研究设计与样本
- 研究生成肝特异性PGC-1β过表达(LivPGC-1β)和PGC-1β敲除(LivPGC-1βKO)小鼠,并以化学和遗传模型进行肝致癌攻击。
主要发现
- 过表达PGC-1β的小鼠显示更高的肿瘤易感性,而PGC-1β敲除小鼠受到保护免受癌变。
- 高水平PGC-1β能增强活性氧(ROS)清除物表达,从而限制有害的ROS积累及随后的凋亡。
- PGC-1β支持肿瘤合成代谢,增强参与脂肪酸和甘油三酯合成的基因表达。
- 肝特异性敲除PGC-1β促进ROS驱动的大分子损伤积累,最终限制肿瘤生长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1β (PGC-1 β) is a master regulator of mitochondrial biogenesis and oxidative metabolism as well as of antioxidant defense. Specifically, in the liver, PGC-1β also promotes de novo lipogenesis, thus sustaining cellular anabolic processes. Given the relevant pathogenic role of mitochondrial and fatty acid metabolism in hepatocarcinoma (HCC), here we pointed to PGC-1β as a putative novel transcriptional player in the development and progression of HCC. For this purpose, we generated both hepatic-specific PGC-1β-overexpressing (LivPGC-1β) and PGC-1β knockout (LivPGC-1βKO) mice, and we challenged them with both chemical and genetic models of hepatic carcinogenesis. Our results demonstrate a pivotal role of PGC-1β in driving liver tumor development. Indeed, whereas mice overexpressing PGC-1β show greater tumor susceptibility, PGC-1β knockout mice are protected from carcinogenesis. High levels of PGC-1β are able to boost reactive oxygen species (ROS) scavenger expression, therefore limiting the detrimental ROS accumulation and, consequently, apoptosis. Moreover, it supports tumor anabolism, enhancing the expression of genes involved in fatty acid and triglyceride synthesis. Accordingly, the specific hepatic ablation of PGC-1β promotes the accumulation of ROS-driven macromolecule damage, finally limiting tumor growth. CONCLUSION: The present data elect hepatic PGC-1β as a transcriptional gatekeeper of mitochondrial function and redox status in HCC, orchestrating different metabolic programs that allow tumor progression. (Hepatology 2018;67:884-898).
引用
- Piccinin E, Peres C, Bellafante E, et al. Hepatic peroxisome proliferator-activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice. Hepatology. 2018. PMID: 28857232. doi:10.1002/hep.29484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。